Comment
. 2010 Nov 18;363(21):2072; author reply 2073-4.
doi: 10.1056/NEJMc1009101.
Rituximab or cyclophosphamide in ANCA-associated renal vasculitis
- PMID: 21083400
- DOI: 10.1056/NEJMc1009101
Item in Clipboard
Comment
Rituximab or cyclophosphamide in ANCA-associated renal vasculitis
N Engl J Med.
.
No abstract available
Comment on
-
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.N Engl J Med. 2010 Jul 15;363(3):211-20. doi: 10.1056/NEJMoa0909169. N Engl J Med. 2010. PMID: 20647198 Clinical Trial.
Similar articles
-
Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.N Engl J Med. 2010 Nov 18;363(21):2073; author reply 2073-4. doi: 10.1056/NEJMc1009101. N Engl J Med. 2010. PMID: 21083398 No abstract available.
-
Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.N Engl J Med. 2010 Nov 18;363(21):2072-3; author reply 2073-4. doi: 10.1056/NEJMc1009101. N Engl J Med. 2010. PMID: 21083399 No abstract available.
-
Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.N Engl J Med. 2010 Nov 18;363(21):2072; author reply 2073-4. doi: 10.1056/NEJMc1009101. N Engl J Med. 2010. PMID: 21083401 No abstract available.
-
S2. Rituximab for ANCA-associated vasculitis: the UK experience.Presse Med. 2013 Apr;42(4 Pt 2):532-4. doi: 10.1016/j.lpm.2013.01.049. Epub 2013 Mar 9. Presse Med. 2013. PMID: 23490639 Review. No abstract available.
-
S3. Rituximab for ANCA-associated vasculitides: the French experience.Presse Med. 2013 Apr;42(4 Pt 2):534-6. doi: 10.1016/j.lpm.2013.01.050. Epub 2013 Feb 26. Presse Med. 2013. PMID: 23453207 Review. No abstract available.
Cited by
-
Risk Factors and Adverse Events Poorly Predict Infections and Hypogammaglobulinemia in Granulomatosis with Polyangiitis Patients Receiving Rituximab.Autoimmune Dis. 2016;2016:8095695. doi: 10.1155/2016/8095695. Epub 2016 Jan 18. Autoimmune Dis. 2016. PMID: 26885383 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
